DIVERSE SCIENTIFIC EXPERTISE AND PROPRIETARY INSIGHTS WILL SUPPORT COMPANY GROWTH AND IMPACT WASHINGTON, April 26, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”), the global science and technology company, announced today the formation of a Scientific Advisory Board (“Board”) to support its innovation and investment strategy. The Board will help the company protect and grow existing... Read more
WASHINGTON, April 22, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the first quarter 2021. All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended April 2, 2021, net earnings were $1.7 billion, or $2.29 per diluted common share which represents a 182.5% year-over-year... Read more
Leading academic and industry cluster to help address 80% of disease-relevant human proteins currently undruggable WALTHAM, Mass. – April, 21, 2021 PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it is serving as a provider and co-developer of assays, instrument solutions and expertise for the PROXIDRUGS Consortium which... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 21, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the BofA Securities 2021 Virtual Health Care Conference on Wednesday, May 12, 2021 at 9:30 a.m. ET. Prahlad Singh, president and chief executive officer of PerkinElmer, will provide... Read more
Thermo Scientific Helios 5 EXL Wafer DualBeam Offers Automation in TEM Sample Prep to Help Accelerate Time-to-Yield HILLSBORO, Ore., April 20, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today unveiled the Helios 5 EXL Wafer DualBeam, designed to meet increasing sample volumes and analysis needs of semiconductor manufacturers as they scale... Read more
Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization – Establishes Thermo Fisher as a global leader in the attractive and high growth clinical research services industry – Adds highly complementary services for the company’s fastest growing end market – Offers both meaningful cost and revenue synergies which will further accelerate growth... Read more
Company also announces appointment of Steve Willoughby as vice president, investor relations WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 13, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates reported and organic revenue growth of 98% and 90%, respectively, for the first quarter ended April 4, 2021. PerkinElmer’s... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the first quarter ended March 31, 2021 in a range of $549 – $554 million, representing reported revenue growth of approximately 30% to 31%, compared to the first quarter of 2020. Adjusting for the impact of foreign currency translation and acquisitions, Bruker estimates... Read more
WASHINGTON, April 13, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) announced today that it expects first quarter 2021 core revenue growth to be above the high-end of the Company’s previously communicated guidance range. For the quarter ended April 2, 2021, the Company expects revenue growth to be approximately 57.0% and non-GAAP core revenue growth... Read more